Author: Khanjan H Nagarsheth, MD, MBA; Chief Editor: Vincent Lopez Rowe, MD more...
Superficial thrombophlebitis is a common inflammatory-thrombotic disorder in which a thrombus develops in a vein located near the surface of the skin. Most superficial veins that develop thrombosis also have phlebitis, in contrast to deep venous thrombosis (DVT), a sometimes asymptomatic condition in which phlebitis may be absent. (See Etiology and Workup.)
Although superficial thrombophlebitis usually occurs in the lower extremities, it also has been described in the penis and the breast ( Mondor disease ). Superficial thrombophlebitis can also develop anywhere that medical interventions occur, such as in the arm or neck (external jugular vein) when intravenous (IV) catheters are used. (See Etiology, Presentation, and Workup.)
Thrombosis and thrombophlebitis of the superficial venous system receive little attention in medical and surgical textbooks. However, thrombophlebitis is encountered frequently and, although it is usually a benign, self-limiting disease, it can be recurrent and tenaciously persistent, at times causing significant incapacitation. (See Epidemiology and Prognosis.)
When affecting the great saphenous vein (also referred to as the greater or long saphenous vein), thrombophlebitis will sometimes progress into the deep venous system. Damage to deep venous valves leads to chronic deep venous insufficiency (often referred to as postphlebitic syndrome), as well as to recurrent pulmonary embolism (PE) and an increased risk of death. [ 1 ]
Causes and sites of development
Superficial thrombophlebitis can occur spontaneously, especially in the lower extremities in the great saphenous vein, or as a complication of medical or surgical interventions. Although the etiology is frequently obscure, superficial venous thrombosis is most often associated with one of the components of the Virchow triad; ie, intimal damage (which can result from trauma, infection, or inflammation), stasis or turbulent flow, or changes in blood constituents (presumably causing increased coagulability). (See Etiology.)
In each type of superficial thrombophlebitis, the condition presents as redness and tenderness along the course of the vein, usually accompanied by swelling. Bleeding also can occur at the site of a varicose vein. (See Presentation.)
Although unusual, superficial thrombophlebitis may occur in the lesser saphenous vein, which empties into the popliteal vein.
Superficial thrombophlebitis can also occur in the external jugular vein, if it has been used for an infusion site. Superficial thrombophlebitis of the upper extremities usually occurs at infusion sites or sites of trauma.
Diagnosis and treatment
Superficial thrombophlebitis is a clinical diagnosis in which the clinician identifies tender and inflamed superficial veins. However, ruling out DVT in the clinical setting is difficult; further testing is often required to evaluate for this condition. (See Presentation and Workup.)
Treatment for superficial thrombophlebitis is aimed at patient comfort and at preventing superficial phlebitis from involving the deep veins. (See Treatment and Medication.)
Superficial phlebitis with infection, such as phlebitis originating at an IV catheter site, is referred to as septic thrombophlebitis , a clinical entity requiring diagnostic and therapeutic approaches that are different from those applied to sterile phlebitis.
Microscopic thrombosis is a normal part of the dynamic balance of hemostasis. In 1846, the German pathologist Virchow recognized that if this dynamic balance were altered by venous stasis or turbulence, abnormal coagulability, or vessel wall injuries, then microthrombi could propagate to form macroscopic thrombi.
In the absence of a triggering event, neither venous stasis nor abnormal coagulability alone causes clinically important thrombosis, but vascular endothelial injury does reliably result in thrombus formation. The initiating injury triggers an inflammatory response that results in immediate platelet adhesion at the injury site. Further platelet aggregation is mediated by thromboxane A2 (TxA2) and by thrombin. A more detailed visual of the coagulation pathway can be seen in the image below.
Blood coagulation (thrombin) and protein C pathways. Courtesy of Wikimedia Commons John H Griffin, PhD.
Verlato F, Zucchetta P, Prandoni P, Camporese G, Marzola MC, Salmistraro G, et al. An unexpectedly high rate of pulmonary embolism in patients with superficial thrombophlebitis of the thigh. J Vasc Surg. 1999 Dec. 30(6):1113-5. [Medline] .
Buerger L. The veins in thromboangiitis obliterans: With particular reference to arteriovenous anastomosis as a cure for the condition. JAMA. 1909. 52:1319.
Shionoya S. Buerger's Disease: Pathology, Diagnosis and Treatment. Nagoya, Japan: University of Nagoya Press; 1990.
Gaffo AL. Thrombosis in vasculitis. Best Pract Res Clin Rheumatol. 2013 Feb. 27(1):57-67. [Medline] .
Pearson T, Bremmer M, Cohen J, Driscoll M. Vasculopathy related to cocaine adulterated with levamisole: A review of the literature. Dermatol Online J. 2012 Jul. 18(7):1. [Medline] .
McColl MD, Ramsay JE, Tait RC, et al. Superficial vein thrombosis: incidence in association with pregnancy and prevalence of thrombophilic defects. Thromb Haemost. 1998 Apr. 79(4):741-2. [Medline] .
Rosendaal FR, Helmerhorst FM, Vandenbroucke JP. Oral contraceptives, hormone replacement therapy and thrombosis. Thromb Haemost. 2001 Jul. 86(1):112-23. [Medline] .
Rush MD, Schoenfeld CN, Watson WA, et al. Skin necrosis and venous thrombosis from subcutaneous injection of charcoal lighter fluid (naptha). Am J Emerg Med. 1998 Sep. 16(5):508-11. [Medline] .
Mermel LA, Allon M, Bouza E, et al. Clinical practice guidelines for the diagnosis and management of intravascular catheter-related infection: 2009 Update by the Infectious Diseases Society of America. Clin Infect Dis. 2009 Jul 1. 49(1):1-45. [Medline] .
DeTakats G. "Resting Infection" in varicose veins, its diagnosis and treatment. Am J Med Sci. 1932. 184:57.
Altemeier WA, Hill EO, Fullen WD. Acute and recurrent thromboembolic disease: a new concept of etiology. Ann Surg. 1969 Oct. 170(4):547-58. [Medline] .
Sproul EE. Carcinoma and venous thrombosis: Frequency of association of carcinoma in body or tail of pancreas with multiple venous thrombosis. Am J Cancer. 1938. 34:566.
Nazir SS, Khan M. Thrombosis of the dorsal vein of the penis (Mondor's Disease): A case report and review of the literature. Indian J Urol. 2010 Jul. 26(3):431-3. [Medline] . [Full Text] .
Bird V, Krasnokutsky S, Zhou HS, et al. Traumatic thrombophlebitis of the superficial dorsal vein of the penis: an occupational hazard. Am J Emerg Med. 1997 Jan. 15(1):67-9. [Medline] .
Markovic MD, Lotina SI, Davidovic LB, et al. [Acute superficial thrombophlebitis--modern diagnosis and therapy]. Srp Arh Celok Lek. 1997 Sep-Oct. 125(9-10):261-6. [Medline] .
Wichers IM, Di Nisio M, Buller HR, et al. Treatment of superficial vein thrombosis to prevent deep vein thrombosis and pulmonary embolism: a systematic review. Haematologica. 2005 May. 90(5):672-7. [Medline] .
Schonauer V, Kyrle PA, Weltermann A, et al. Superficial thrombophlebitis and risk for recurrent venous thromboembolism. J Vasc Surg. 2003 Apr. 37(4):834-8. [Medline] .
de Godoy JM, Braile DM. Protein S deficiency in repetitive superficial thrombophlebitis. Clin Appl Thromb Hemost. 2003 Jan. 9 (1):61-2. [Medline] .
Gillet JL, Ffrench P, Hanss M, Allaert FA, Chleir F. [Predictive value of D-dimer assay in superficial thrombophlebitis of the lower limbs]. J Mal Vasc. 2007 Apr. 32(2):90-5. [Medline] .
Lutter KS, Kerr TM, Roedersheimer LR, et al. Superficial thrombophlebitis diagnosed by duplex scanning. Surgery. 1991 Jul. 110(1):42-6. [Medline] .
Bergqvist D, Jaroszewski H. Deep vein thrombosis in patients with superficial thrombophlebitis of the leg. Br Med J (Clin Res Ed). 1986 Mar 8. 292(6521):658-9. [Medline] . [Full Text] .
Qur I, Leizorovicz A, Galanaud JP, Presles E, Barrellier MT, Becker F, et al. Superficial venous thrombosis and compression ultrasound imaging. J Vasc Surg. 2012 Oct. 56 (4):1032-8.e1. [Medline] .
Stevens SM. Review: Fondaparinux reduces VTE and recurrence in superficial thrombophlebitis of the leg. Ann Intern Med. 2012 Aug 21. 157(4):JC2-4. [Medline] .
Prandoni P, Tormene D, Pesavento R,. High vs. low doses of low-molecular-weight heparin for the treatment of superficial vein thrombosis of the legs: a double-blind, randomized trial. J Thromb Haemost. 2005 Jun. 3(6):1152-7. [Medline] .
Di Nisio M, Wichers IM, Middeldorp S. Treatment for superficial thrombophlebitis of the leg. Cochrane Database Syst Rev. 2007 Apr 18. CD004982. [Medline] .
Di Nisio M, Wichers IM, Middeldorp S. Treatment for superficial thrombophlebitis of the leg. Cochrane Database Syst Rev. 2013 Apr 30. 4:CD004982. [Medline] .
Decousus H, Prandoni P, Mismetti P, et al. Fondaparinux for the treatment of superficial-vein thrombosis in the legs. N Engl J Med. 2010 Sep 23. 363(13):1222-32. [Medline] .
Bijsterveld NR, Moons AH, Boekholdt SM, et al. Ability of recombinant factor VIIa to reverse the anticoagulant effect of the pentasaccharide fondaparinux in healthy volunteers. Circulation. 2002 Nov 12. 106(20):2550-4. [Medline] .
Ascher E, Hanson JN, Salles-Cunha S, et al. Lesser saphenous vein thrombophlebitis: its natural history and implications for management. Vasc Endovascular Surg. 2003 Nov-Dec. 37(6):421-7. [Medline] .
Di Minno MN, Ambrosino P, Ambrosini F, Tremoli E, Di Minno G, Dentali F. Prevalence of deep vein thrombosis and pulmonary embolism in patients with superficial vein thrombosis: a systematic review and meta-analysis. J Thromb Haemost. 2016 May. 14 (5):964-72. [Medline] .
Lozano FS, Almazan A. Low-molecular-weight heparin versus saphenofemoral disconnection for the treatment of above-knee greater saphenous thrombophlebitis: a prospective study. Vasc Endovascular Surg. 2003 Nov-Dec. 37 (6):415-20. [Medline] .
Quenet S, Laporte S, Dcousus H, et al. Factors predictive of venous thrombotic complications in patients with isolated superficial vein thrombosis. J Vasc Surg. 2003 Nov. 38(5):944-9. [Medline] .
Rathbun SW, Aston CE, Whitsett TL. A randomized trial of dalteparin compared with ibuprofen for the treatment of superficial thrombophlebitis. J Thromb Haemost. 2012 May. 10 (5):833-9. [Medline] .
Glasser ST. Principles of Peripheral Vascular Surgery. Philadelphia: FA Davis; 1959.
Grski G, Szopinski P, Michalak J, et al. Liposomal heparin spray: a new formula in adjunctive treatment of superficial venous thrombosis. Angiology. 2005 Jan-Feb. 56(1):9-17. [Medline] .
Johnson G, DePalma RG. Superficial thrombophlebitis: diagnosis and management. Rutherford's Vascular Surgery. 5th ed. Philadelphia: WB Saunders; 1998. Vol 1: 1979, section XIX.
Kim J, Richards S, Kent PJ. Clinical examination of varicose veins--a validation study. Ann R Coll Surg Engl. 2000 May. 82(3):171-5. [Medline] . [Full Text] .
Marchiori A, Verlato F, Sabbion P, et al. High versus low doses of unfractionated heparin for the treatment of superficial thrombophlebitis of the leg. A prospective, controlled, randomized study. Haematologica. 2002 May. 87(5):523-7. [Medline] .
Murray CK, Beckius ML, McAllister K. Fusarium proliferatum superficial suppurative thrombophlebitis. Mil Med. 2003 May. 168(5):426-7. [Medline] .
Neher JO, Safranek S, Greenwald JL. Clinical inquiries. What is the best therapy for superficial thrombophlebitis?. J Fam Pract. 2004 Jul. 53(7):583-5. [Medline] .
Superficial Thrombophlebitis Treated by Enoxaparin Study Group. A pilot randomized double-blind comparison of a low-molecular-weight heparin, a nonsteroidal anti-inflammatory agent, and placebo in the treatment of superficial vein thrombosis. Arch Intern Med. 2003 Jul 28. 163(14):1657-63. [Medline] .
Wester JP, Kuenen BC, Meuwissen OJ, et al. Mondor's disease as first thrombotic event in hereditary protein C deficiency and anticardiolipin antibodies. Neth J Med. 1997 Feb. 50(2):85-7. [Medline] .
Deep venous thrombosis.
Thrombosis of great saphenous vein and tributaries. Note lack of full compressibility of vein secondary to intraluminal thrombus. Courtesy of Wikimedia Commons Nevit Dilmen.
Blood coagulation (thrombin) and protein C pathways. Courtesy of Wikimedia Commons John H Griffin, PhD.